Chronic dyspnea, or persistent shortness of breath, is a common symptom in patients with respiratory, cardiovascular, or neuromuscular disorders. It can significantly impair daily activities, reduce exercise tolerance, and diminish quality of life. Causes range from chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary hypertension to heart failure, anemia, and obesity. Assessment involves a comprehensive clinical evaluation, including pulmonary function tests, imaging, cardiopulmonary exercise testing, and evaluation of comorbidities to determine the underlying contributors and severity of breathlessness. Tailoring interventions based on these findings is crucial for achieving meaningful chronic dyspnea relief.
Management strategies combine pharmacologic, non-pharmacologic, and supportive measures. Medications such as bronchodilators, corticosteroids, and diuretics are used depending on the underlying pathology to improve airflow, reduce inflammation, and manage fluid overload. Non-drug approaches, including pulmonary rehabilitation, structured aerobic exercise, breathing retraining, and energy-conservation techniques, enhance respiratory efficiency and reduce the perception of breathlessness. Supplemental oxygen may be prescribed for patients with chronic hypoxemia, while anxiety and fatigue associated with dyspnea are addressed through cognitive behavioral therapy or relaxation strategies. Patient education on symptom recognition, pacing activities, and adherence to treatment plans is essential. Multidisciplinary care involving pulmonologists, cardiologists, physiotherapists, and respiratory therapists ensures a holistic approach. Implementing comprehensive strategies for chronic dyspnea relief improves functional capacity, supports independence, and enhances overall well-being for patients living with long-term respiratory challenges.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation